The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions: Randomized Trial

The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions: Randomized Trial

Brief description of study

We are interested in comparing 3 care conditions to determine which condition is best to help people with opioid use disorder (OUD) and mental illness reduce their drug use and improve their psychiatric symptoms. The model we are testing is called collaborative care. This model uses a team-based approach in which a primary care physician (PCP) and a care manager coordinate care. Care managers are hired in primary care practices to work as part of the health care team. As part of this study, care managers will keep their role and continue to provide care monitoring of patients with mental health conditions in the primary care practice. As part of this study, care managers in the experimental conditions will also receive training in treating patients with OUD. You will be offered medication for opioid use disorders (MOUD) such as buprenorphine. Buprenorphine, in combination with counseling, provides a whole-patient approach to the treatment of OUD. When taken as prescribed, buprenorphine is safe and effective. Buprenorphine lowers your risk for misuse and reduces withdrawal symptoms and cravings. It also helps reduce the chances of overdose.

Detailed description of study

Due to COVID-19 we will be conducting all follow up research interviews and many baseline research interviews for this study over the phone. An exception is that we may ask you to come to our offices at 3535 Market St. in Philadelphia to provide a urine drug screen. Please note that once COVID-19 restrictions have been removed, we will continue the study with both in-person and phone visits. We will let you know when this takes place and which interviews will be done over the phone versus in-person. We will ask you to review this consent form again with the updated changes. Research staff will contact you to complete the interviews at times that are good for you.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Mental Health,OUD,Opoid use disorder
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 09 Mar 2024. Study ID: 834490
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center